4//SEC Filing
de Garidel Marc 4
Accession 0001209191-23-005596
CIK 0001868734other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 8:08 PM ET
Size
5.3 KB
Accession
0001209191-23-005596
Insider Transaction Report
Form 4
de Garidel Marc
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-01-26+200,000→ 212,500 total
Footnotes (1)
- [F1]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-fourth (1/4) of the RSUs shall vest on January 26, 2024 and the remaining RSUs shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continuous service through each such vesting date; provided that, in the event the previously announced pending acquisition of the Issuer by AstraZeneca PLC occurs, 50% of the RSUs shall vest immediately prior to the closing of such transaction, subject to the Reporting Person's continuous service through such date, and the remaining 50% of the RSUs shall be cancelled as of such date.
Documents
Issuer
CinCor Pharma, Inc.
CIK 0001868734
Entity typeother
Related Parties
1- filerCIK 0001901033
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 8:08 PM ET
- Size
- 5.3 KB